Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
4.48M
-
Shares change
-
-237K
-
Total reported value, excl. options
-
$14.5M
-
Value change
-
-$783K
-
Number of buys
-
16
-
Number of sells
-
-27
-
Price
-
$3.24
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2025
62 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2025.
XBiotech Inc. - Common Shares, no par value (XBIT) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.48M shares
of 30.8M outstanding shares and own 14.55% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1.29M shares), VANGUARD GROUP INC (1.06M shares), GEODE CAPITAL MANAGEMENT, LLC (461K shares), STATE STREET CORP (230K shares), NORTHERN TRUST CORP (209K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (123K shares), MORGAN STANLEY (105K shares), AMERICAN CENTURY COMPANIES INC (102K shares), Bank of New York Mellon Corp (91.1K shares), and MILLENNIUM MANAGEMENT LLC (82.4K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.